1&1 AG (0E6Y)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 23.78 |
|---|---|
| 52-week range | 18.72 – 27.24 |
| Return, 1 month / 3 months | −0.9% / +16.0% |
| Return, 1 year / 3 years | +10.2% / +50.7% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 33.5% |
| Worst drawdown (1 year) | -29.5% |
| Average daily value traded | 0.64M EUR |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
1&1 AG is a German telecommunications company based in Montabaur that provides mobile and fixed-line services to consumers and business customers. It offers mobile phone contracts, DSL and fibre broadband connections, and related internet services, operating as a mobile virtual network operator that uses partner networks to carry its traffic. The company also supplies hardware and accessories alongside its service plans, and it belongs to the United Internet group of businesses.
The shares are listed on the London Exchange in UK under the code 0E6Y, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
1&1 AG (0E6Y) trades on the London Exchange in UK. It last closed at EUR 23.78 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,799 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.2% and over the last three months it rose 16.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.1% | ||
| From 52-week high | -11.9% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 16.0% | ||
| 6-month return | 2.5% | ||
| 12-month return, skipping the last month | 11.2% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.5% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.64M EUR | ||
| Zero-volume days | 18.3% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.0% |
|---|---|
| 1 month | −0.9% |
| 3 months | +16.0% |
| 6 months | +2.5% |
| 1 year | +10.2% |
| 3 years | +50.7% |
| 5 years | −7.1% |
Signals
| 50-day / 200-day average | 23.09 / 23.05 |
|---|---|
| Golden / death cross (60 days) | Golden, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | EUR 0.0500 |
| 15 May 2025 | EUR 0.0500 |
| 17 May 2024 | EUR 0.0500 |
| 17 May 2023 | EUR 0.0500 |
| 19 May 2022 | EUR 0.0500 |
| 27 May 2021 | EUR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.